Cargando…

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease

An imbalance in the circulatory and organ-specific renin-angiotensin system (RAS) pathways is associated with age-related dysfunction and disease including cardiovascular burden and more recently Alzheimer’s disease (AD). It is currently unclear whether an age-associated imbalance in components of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacLachlan, Robert, Evans, Charles E., Chai, Siew Yeen, Good, Mark A., Kehoe, Patrick Gavin, Miners, J. Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997187/ https://www.ncbi.nlm.nih.gov/pubmed/36911263 http://dx.doi.org/10.1016/j.nbas.2022.100062

Ejemplares similares

Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer’s Disease
por: MacLachlan, Robert, et al.
Publicado: (2022)

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
por: Evans, Charles E., et al.
Publicado: (2020)

Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia
por: Tayler, Hannah, et al.
Publicado: (2021)

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer’s disease
por: AL Mulhim, Noura S., et al.
Publicado: (2019)

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
por: Asby, Daniel, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado: (2016)

CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology
por: Miners, J. S., et al.
Publicado: (2019)

Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice
por: Kyrkanides, Stephanos, et al.
Publicado: (2011)

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
por: Fisher, Robert A., et al.
Publicado: (2022)

The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer’s Disease Pathology
por: Cui, Huan, et al.
Publicado: (2021)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Ke, Yazi D., et al.
Publicado: (2009)

Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease
por: Katsouri, Loukia, et al.
Publicado: (2019)

COPD exacerbations by disease severity in England
por: Merinopoulou, Evie, et al.
Publicado: (2016)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Dapsone is an anticatalysis for Alzheimer’s disease exacerbation
por: Lee, Jong Hoon, et al.
Publicado: (2022)

Cholinergic basal forebrain degeneration due to sleep-disordered breathing exacerbates pathology in a mouse model of Alzheimer’s disease
por: Qian, Lei, et al.
Publicado: (2022)

Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease
por: Miners, J. Scott, et al.
Publicado: (2015)

Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
por: Herline, Krystal, et al.
Publicado: (2018)

BIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging
por: Glennon, Elizabeth B. C., et al.
Publicado: (2013)

Sustained high body temperature exacerbates cognitive function and Alzheimer’s disease-related pathologies
por: Jung, Cha-Gyun, et al.
Publicado: (2022)

The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
por: Kehoe, Patrick Gavin
Publicado: (2018)

Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology
por: Kastanenka, Ksenia V., et al.
Publicado: (2019)

Upregulation of Prickle2 Ameliorates Alzheimer’s Disease-Like Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
por: Sun, Fengxian, et al.
Publicado: (2020)

High plasticity of axonal pathology in Alzheimer’s disease mouse models
por: Blazquez-Llorca, Lidia, et al.
Publicado: (2017)

Adaptable toolbox to characterize Alzheimer’s disease pathology in mouse models
por: Huang, Youtong, et al.
Publicado: (2022)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
por: Kidana, Kiwami, et al.
Publicado: (2018)

High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice
por: Thériault, Peter, et al.
Publicado: (2016)

A high‐fat diet exacerbates the Alzheimer's disease pathology in the hippocampus of the App (NL−F/NL−F) knock‐in mouse model
por: Mazzei, Guianfranco, et al.
Publicado: (2021)

Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer’s disease
por: Winkeler, A., et al.
Publicado: (2008)

Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model
por: Ding, Jiuyang, et al.
Publicado: (2021)

Overexpression of endophilin A1 exacerbates synaptic alterations in a mouse model of Alzheimer’s disease
por: Yu, Qing, et al.
Publicado: (2018)

The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer’s Disease
por: Webberley, Thomas S., et al.
Publicado: (2022)

Cadmium, an Environmental Contaminant, Exacerbates Alzheimer’s Pathology in the Aged Mice’s Brain
por: Ali, Tahir, et al.
Publicado: (2021)

Mouse Models of Alzheimer’s Disease
por: Yokoyama, Miyabishara, et al.
Publicado: (2022)

Role of liraglutide in Alzheimer’s disease pathology
por: Vargas-Soria, Maria, et al.
Publicado: (2021)

TDP-43 Pathology in Alzheimer’s Disease
por: Meneses, Axel, et al.
Publicado: (2021)

Differential Network Analyses of Alzheimer's Disease Identify Early Events in Alzheimer's Disease Pathology
por: Xia, Jing, et al.
Publicado: (2014)

The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease
por: Liu, Jie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3u6vb1b799vvvc2f7asm1g7kv4